| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130022990 Cellular labeling for nuclear magnetic resonance techniques |
| 01/24/2013 | US20130022542 Radiolabelled rotenone derivatives and their use in spect imaging |
| 01/24/2013 | US20130022541 FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death |
| 01/24/2013 | US20130022540 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 01/24/2013 | US20130022539 Ovr115 antibody compositions and methods of use |
| 01/24/2013 | US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use |
| 01/24/2013 | CA2842195A1 Fty720 increases cd74 expression and sensitizes cancer cells to anti-cd74 antibody-mediated cell death |
| 01/24/2013 | CA2841313A1 Sugar alcohol-based crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof |
| 01/23/2013 | EP2548583A2 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 01/23/2013 | CN102892787A Radioactive metal-labeled anti-cadherin antibody |
| 01/23/2013 | CN102391318B Fluorine-18 fluorodeoxyglucose (18F-FDG) kit and application thereof in synthesis of positron emission tomography (PET) developer FDG |
| 01/22/2013 | US8357350 Annulus fibrosus detection in intervertebral discs using molecular imaging agents |
| 01/22/2013 | US8357349 Compounds for treatment of copper overload |
| 01/17/2013 | WO2013007660A1 Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors |
| 01/17/2013 | WO2012160450A3 Modular transport platform for targeted delivery of therapeutic agents |
| 01/17/2013 | WO2012157900A3 18f-labeled precursor of pet radioactive medical supplies, and preparation method thereof |
| 01/17/2013 | US20130017150 Methods for prevention and treatment of acute renal injury |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | US20130017148 Systems for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/17/2013 | US20130017147 Targeting agent for tumor site |
| 01/17/2013 | CA2841238A1 Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors |
| 01/16/2013 | EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
| 01/16/2013 | CN102872463A Nanoparticles comprising rna ligands |
| 01/16/2013 | CN102872449A Method for establishing hypothyroidism Wistar rat eye socket model |
| 01/16/2013 | CN102871986A Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/16/2013 | CN101967149B Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of nitryl and preparation and application |
| 01/16/2013 | CN101723847B Novel 18F labeled p-nitro benzoyl amino acid compound and preparation method and application thereof |
| 01/16/2013 | CN101678129B Radioactive pet agents for imaging CCR5 in vivo |
| 01/15/2013 | US8354512 Ligand and metal complex |
| 01/15/2013 | US8354094 Pharmaceutical composition of nanoparticles |
| 01/15/2013 | US8354093 Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer |
| 01/15/2013 | US8354092 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry |
| 01/10/2013 | WO2013006764A1 Method of treating cholangiocarcinoma and apparatus |
| 01/10/2013 | WO2013003912A1 Cryptate compounds |
| 01/10/2013 | US20130011336 Imaging agents of fibrotic diseases |
| 01/10/2013 | US20130011335 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and SRC |
| 01/10/2013 | US20130011334 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 01/10/2013 | US20130011333 Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery |
| 01/10/2013 | US20130011332 Frozen Compositions and Methods for Piercing a Substrate |
| 01/10/2013 | CA2839466A1 Method of treating cholangiocarcinoma and apparatus |
| 01/09/2013 | EP2543666A1 Radioactive iodine labeled organic compound or salt thereof |
| 01/09/2013 | EP2542155A2 Cancer diagnosis and imaging |
| 01/09/2013 | CN102861347A 99mTc labeling galactosed arginyl-glycyl-aspartic acid (RGD) tumor diagnosis medicine and preparation method |
| 01/09/2013 | CN102861346A PET/CT (Positron Emission Tomography/Computed Tomography) in vivo molecular imaging probe 18F-Annexin B1 for apoptosis and preparation method and purposes thereof |
| 01/08/2013 | US8349391 Radium target and method for producing it |
| 01/08/2013 | CA2531118C Multivalent carriers of bi-specific antibodies |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2459514C An enzymatic process for the synthesis of organo-fluorine compounds |
| 01/03/2013 | WO2012122471A3 Compounds and methods of use in ablative radiotherapy |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004422 Benzothiazole derivative compounds, compositions and uses |
| 01/03/2013 | US20130004421 Radiolabeled affibody molecules |
| 01/03/2013 | US20130004420 Hypervalent radioactive astatine or iodine compounds, and preparation methods thereof |
| 01/03/2013 | US20130004419 Carbonylporphyrins and Uses Thereof |
| 01/03/2013 | US20130004418 Infiltration solution for treating an enamel lesion |
| 01/03/2013 | US20130004417 Gold Coated Lanthanide Nanoparticles |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | US20130004415 Joint-Homing Peptides and Uses Thereof |
| 01/03/2013 | US20130004414 Devices and methods for reducing radiolysis of radioisotopes |
| 01/02/2013 | EP2538982A1 Pet monitoring of ab-directed immunotherapy |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858793A Affinity Peptides Toward Bmp-2 |
| 01/02/2013 | CN102858367A Composite body for antigen or drug delivery |
| 01/02/2013 | CN102065906B Methods for radiolabelling macromolecules |
| 01/02/2013 | CN101970016B Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/02/2013 | CN101703786B Natural macromolecular ultrafine fibrous membrane marked with radioactive nuclide and preparation method thereof |
| 01/01/2013 | US8343927 Pharmaceutical compositions for prevention of overdose or abuse |
| 01/01/2013 | US8343515 Perfluorocarbon gel formulations |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 01/01/2013 | US8343461 Molecular signature of cancer |
| 01/01/2013 | US8343460 Methods and compositions for F-18 labeling of proteins, peptides and molecules |
| 01/01/2013 | US8343459 Method for production of radiation diagnostic imaging agent |
| 01/01/2013 | US8343458 Probes for in vivo targeting of active cysteine proteases |
| 01/01/2013 | US8343457 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 12/27/2012 | WO2012178173A1 Extracellular targeted drug conjugates |
| 12/27/2012 | WO2012177624A2 Focused radiation for augmenting immune-based therapies against neoplasms |
| 12/27/2012 | WO2012176587A1 Novel compound with amyloid affinity |
| 12/27/2012 | WO2012175641A1 Formulations of fluorinated stilbene suitable for pet imaging |
| 12/27/2012 | US20120328521 Formulations suitable for pet imaging with hydrophobic pet agents |
| 12/27/2012 | US20120328520 Conjugate with target-finding ligand and use thereof |
| 12/27/2012 | US20120328519 Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases |
| 12/27/2012 | US20120328518 Prostate specific membrane antigen inhibitors |
| 12/27/2012 | US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof |
| 12/27/2012 | US20120328516 Method of radiotherapy using a radiolabelled rgd peptide |
| 12/27/2012 | US20120328515 In vivo detection of apoptosis |
| 12/27/2012 | US20120328514 N-alkoxyamide conjugates as imaging agents |
| 12/27/2012 | US20120328513 Compositions against cancer antigen liv-1 and uses thereof |
| 12/27/2012 | US20120328512 Fibrin-Binding Peptides and Conjugates Thereof |
| 12/27/2012 | US20120328511 Novel Antigen Binding Proteins |
| 12/27/2012 | CA2840170A1 Focused radiation for augmenting immune-based therapies against neoplasms |
| 12/27/2012 | CA2839961A1 Formulations of fluorinated stilbene suitable for pet imaging |
| 12/27/2012 | CA2839199A1 Novel compound with amyloid affinity |
| 12/26/2012 | EP2537854A1 Methode for producing f-labelled compound and high molecular compound to be used in the method |
| 12/26/2012 | EP2536691A1 Bifunctional chelating agents |
| 12/26/2012 | EP2536468A1 Treatment of chronic inflammatory conditions |
| 12/26/2012 | EP2536438A1 Composition for treating liver cancer in humans based on rhenium-188 and method for preparing such a composition |